Insider · CIK 0001569877

Chan Andrew K

Reports to the SEC for 1 company · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001569877

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-19	Cellular Biomedicine Group, Inc.A Award	Ch Legal Ofr, Corp Dev & Sec	AAward	+48K sh	—	—	239,747
2021-02-19	Cellular Biomedicine Group, Inc.D Disposition to Issuer	Ch Legal Ofr, Corp Dev & Sec	DDisposition to Issuer	−240K sh	—	—	0
2021-02-19	Cellular Biomedicine Group, Inc.Employee Stock Options (Right to Buy)D Disposition to Issuer	Ch Legal Ofr, Corp Dev & Sec	DDisposition to Issuer	−38.9K sh	—	—	0
2021-02-19	Cellular Biomedicine Group, Inc.Employee Stock Options (Right to Buy)D Disposition to Issuer	Ch Legal Ofr, Corp Dev & Sec	DDisposition to Issuer	−37.9K sh	—	—	0
2021-02-19	Cellular Biomedicine Group, Inc.Employee Stock Options (Right to Buy)J Other	Ch Legal Ofr, Corp Dev & Sec	JOther	−15K sh	—	—	0
2021-02-19	Cellular Biomedicine Group, Inc.Employee Stock Options (Right to Buy)D Disposition to Issuer	Ch Legal Ofr, Corp Dev & Sec	DDisposition to Issuer	−15K sh	—	—	0
2021-02-19	Cellular Biomedicine Group, Inc.Employee Stock Options (Right to Buy)D Disposition to Issuer	Ch Legal Ofr, Corp Dev & Sec	DDisposition to Issuer	−23K sh	—	—	0
2019-12-12	Cellular Biomedicine Group, Inc.A Award	Ch Legal Ofr, Corp Dev & Sec	AAward	+20K sh	—	—	195,810
2019-10-28	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−485 sh	$15.08	−$7,313.8	191,746
2019-09-27	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−485 sh	$14.68	−$7,119.8	192,231
2019-08-27	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−486 sh	$11.47	−$5,574.42	192,716
2019-07-29	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−486 sh	$13.70	−$6,658.2	193,202
2019-06-27	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−486 sh	$14.94	−$7,260.84	193,688
2019-05-28	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−486 sh	$16.94	−$8,232.84	194,174
2019-04-29	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−486 sh	$16.89	−$8,208.54	194,660
2019-03-27	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−486 sh	$16.80	−$8,164.8	195,146
2019-02-27	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−178 sh	$18.06	−$3,214.68	195,632
2019-01-31	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−178 sh	$17.69	−$3,148.82	175,810
2018-12-27	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−178 sh	$17.64	−$3,139.92	21,898
2018-11-27	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−178 sh	$18.07	−$3,216.46	22,076
2018-10-26	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−168 sh	$12.75	−$2,142	22,254
2018-09-27	Cellular Biomedicine Group, Inc.F Tax Payment	Ch Legal Ofr, Corp Dev & Sec	FTax Payment	−154 sh	$22.00	−$3,388	22,422
2018-08-27	Cellular Biomedicine Group, Inc.F Tax Payment	Ch Legal Ofr, Corp Dev & Sec	FTax Payment	−106 sh	$20.85	−$2,210.1	22,576
2018-07-27	Cellular Biomedicine Group, Inc.F Tax Payment	Ch Legal Ofr, Corp Dev & Sec	FTax Payment	−106 sh	$20.60	−$2,183.6	22,682
2018-06-27	Cellular Biomedicine Group, Inc.F Tax Payment	Ch Legal Ofr, Corp Dev & Sec	FTax Payment	−106 sh	$19.55	−$2,072.3	22,788
2018-05-27	Cellular Biomedicine Group, Inc.F Tax Payment	Ch Legal Ofr, Corp Dev & Sec	FTax Payment	−106 sh	$17.10	−$1,812.6	22,894
2017-12-22	Cellular Biomedicine Group, Inc.P Purchase	Ch Legal Ofr, Corp Dev & Sec	PPurchase	+8,333 sh	$12.00	+$100K	154,090
2017-03-27	Cellular Biomedicine Group, Inc.A Award	Ch Legal Ofr, Corp Dev & Sec	AAward	+23K sh	—	—	23,000
2017-03-03	Cellular Biomedicine Group, Inc.Non-Qualified Stock Option (right to buy) (2014 Plan)A Award	Ch Legal Ofr, Corp Dev & Sec	AAward	+23K sh	—	—	23,000
2017-01-20	Cellular Biomedicine Group, Inc.Non-Qualified Stock Option (right to buy) (2011 Plan)A Award	Ch Legal Ofr, Corp Dev & Sec	AAward	+15K sh	—	—	15,000
2016-04-08	Cellular Biomedicine Group, Inc.Employee Stock Option (Right to Buy)A Award	Ch Legal Ofr, Corp Dev & Sec	AAward	+15K sh	—	—	15,000
2016-02-22	Cellular Biomedicine Group, Inc.M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	+1,307 sh	$3.00	+$3,921	147,054
2016-02-22	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−1,307 sh	$18.22	−$23.8K	145,747
2016-02-22	Cellular Biomedicine Group, Inc.Non- Qualified Stock Option (right to buy) (2011 Plan)M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	−1,307 sh	—	—	38,880
2016-02-17	Cellular Biomedicine Group, Inc.M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	+1,516 sh	$5.61	+$8,504.76	147,263
2016-02-17	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−1,516 sh	$17.76	−$26.9K	145,747
2016-02-17	Cellular Biomedicine Group, Inc.Non- Qualified Stock Option (right to buy) (2013 Plan)M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	−1,516 sh	—	—	37,904
2016-01-21	Cellular Biomedicine Group, Inc.M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	+1,296 sh	$3.00	+$3,888	147,053
2016-01-21	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−1,296 sh	$13.87	−$18K	145,747
2016-01-21	Cellular Biomedicine Group, Inc.Non- Qualified Stock Option (right to buy) (2011 Plan)M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	−1,296 sh	—	—	40,187
2016-01-19	Cellular Biomedicine Group, Inc.M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	+1,516 sh	$5.61	+$8,504.76	147,273
2016-01-19	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−1,516 sh	$12.07	−$18.3K	145,757
2016-01-19	Cellular Biomedicine Group, Inc.Non- Qualified Stock Option (right to buy) (2013 Plan)M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	−1,516 sh	—	—	39,420
2015-12-21	Cellular Biomedicine Group, Inc.M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	+1,296 sh	$3.00	+$3,888	144,241
2015-12-21	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−1,296 sh	$22.26	−$28.8K	142,945
2015-12-21	Cellular Biomedicine Group, Inc.Non- Qualified Stock Option (right to buy) (2011 Plan)M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	−1,296 sh	—	—	42,759
2015-12-18	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−10K sh	$22.00	−$220K	142,945
2015-12-17	Cellular Biomedicine Group, Inc.M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	+1,516 sh	$5.61	+$8,504.76	154,461
2015-12-17	Cellular Biomedicine Group, Inc.S Sale	Ch Legal Ofr, Corp Dev & Sec	SSale	−1,516 sh	$21.28	−$32.3K	152,945
2015-12-17	Cellular Biomedicine Group, Inc.Non- Qualified Stock Option (right to buy) (2013 Plan)M Exercise/Conversion	Ch Legal Ofr, Corp Dev & Sec	MExercise/Conversion	−1,516 sh	—	—	42,452

Recent filings

Accepted (ET)
Feb 194
Chan Andrew K0001654954-21-001899
SEC(opens sec.gov)
Feb 135
Chan Andrew K0001654954-20-001540
SEC(opens sec.gov)
Feb 145
Chan Andrew K0001654954-19-001597
SEC(opens sec.gov)

Companies

Cellular Biomedicine Group, Inc.Ch Legal Ofr, Corp Dev & Sec

Address

530 UNIVERSITY AVENUE, #17

PALO ALTO, CA, 94301